Selected article for: "acute respiratory syndrome and lung dysfunction"

Author: Kubra, Khadeja-Tul; Uddin, Mohammad A.; Akhter, Mohammad S.; Barabutis, Nektarios
Title: Luminespib counteracts the Kifunensine-induced lung endothelial barrier dysfunction
  • Cord-id: wkb53uv3
  • Document date: 2020_9_24
  • ID: wkb53uv3
    Snippet: Unfolded protein response (UPR) suppression by Kifunensine has been associated with lung hyperpermeability, the hallmark of Acute Respiratory Distress Syndrome. The present study investigates the effects of the heat shock protein 90 inhibitor Luminespib (AUY-922) towards the Kifunensine-triggered lung endothelial dysfunction. Our results indicate that the UPR inducer Luminespib counteracts the effects of Kifunensine in both human and bovine lung endothelial cells. Hence, we suggest that mild UPR
    Document: Unfolded protein response (UPR) suppression by Kifunensine has been associated with lung hyperpermeability, the hallmark of Acute Respiratory Distress Syndrome. The present study investigates the effects of the heat shock protein 90 inhibitor Luminespib (AUY-922) towards the Kifunensine-triggered lung endothelial dysfunction. Our results indicate that the UPR inducer Luminespib counteracts the effects of Kifunensine in both human and bovine lung endothelial cells. Hence, we suggest that mild UPR induction may serve as a promising therapeutic strategy against potentially lethal respiratory disorders, including the ARDS related to COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory and lung endothelial dysfunction: 1, 2, 3, 4
    • acute respiratory and lung hyperpermeability: 1, 2, 3
    • acute respiratory distress syndrome and lung endothelial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lung endothelial dysfunction: 1, 2, 3
    • acute respiratory distress syndrome and lung hyperpermeability: 1, 2